Comparision of IPACK and Periarticular Block With Adductor Block Alone After Total Knee Artroplasty
1 other identifier
interventional
105
1 country
1
Brief Summary
105 patients ASA I-III, undergoing total knee arthroplasty under spinal anesthesia, will be randomly assigned into one of three groups, namely group A (n=35), where an adductor canal block, group B (N:35) where an adductor canal block with IPCAK, and group C (n=35) where an adductor canal block with PAI will be performed preoperatively. All patients will receive a standardized multimodal approach. NRS scores will be evaluated in static and dynamic conditions during the first 48 hours postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2021
CompletedFirst Posted
Study publicly available on registry
June 18, 2021
CompletedStudy Start
First participant enrolled
June 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 8, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 17, 2021
CompletedAugust 18, 2021
August 1, 2021
2 months
June 9, 2021
August 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
NRS scores
Numerical Rating Scale (NRS) scores (Range 0-10, 0=no pain, 10=the worse pain ever)
48 hours
Secondary Outcomes (7)
Opioid consumption
4-6-8-12-24 and 48 hours
Range of knee motion
48 hours
Complications
48 hours
Patient satisfaction
48 hours
Incidence of adverse events related to nerve block procedures
Post-op 24 to 72 hours
- +2 more secondary outcomes
Study Arms (3)
Group A
ACTIVE COMPARATORAdductor canal block
Group B
ACTIVE COMPARATORAdductor canal block plus IPACK
Group C
ACTIVE COMPARATORAdductor canal block plus PAI
Interventions
Adductor Canal Block plus IPACK Block using bupivacaine
Adductor Canal Block plus PAI Block using bupivacaine
Eligibility Criteria
You may qualify if:
- Physical status according to American Society of Anesthesiologists (ASA) I-III
- Patients scheduled for total knee arthroplasty
You may not qualify if:
- Previous operation on same knee
- Hepatic or renal insufficiency
- Younger than 18 years old and older than 85
- Patients undergoing general anesthesia
- Allergy or intolerance to one of the study medications
- BMI \> 40
- ASA IV
- Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
- Chronic opioid use (taking opioids for longer than 3 months, or daily oral morphine equivalent of \>5mg/day for one month)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karaman Training and Research Hospital
Karaman, 70200, Turkey (Türkiye)
Related Publications (2)
Kertkiatkachorn W, Kampitak W, Tanavalee A, Ngarmukos S. Adductor Canal Block Combined With iPACK (Interspace Between the Popliteal Artery and the Capsule of the Posterior Knee) Block vs Periarticular Injection for Analgesia After Total Knee Arthroplasty: A Randomized Noninferiority Trial. J Arthroplasty. 2021 Jan;36(1):122-129.e1. doi: 10.1016/j.arth.2020.06.086. Epub 2020 Jul 2.
PMID: 32694032BACKGROUNDKim DH, Beathe JC, Lin Y, YaDeau JT, Maalouf DB, Goytizolo E, Garnett C, Ranawat AS, Su EP, Mayman DJ, Memtsoudis SG. Addition of Infiltration Between the Popliteal Artery and the Capsule of the Posterior Knee and Adductor Canal Block to Periarticular Injection Enhances Postoperative Pain Control in Total Knee Arthroplasty: A Randomized Controlled Trial. Anesth Analg. 2019 Aug;129(2):526-535. doi: 10.1213/ANE.0000000000003794.
PMID: 30234517BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2021
First Posted
June 18, 2021
Study Start
June 22, 2021
Primary Completion
August 8, 2021
Study Completion
August 17, 2021
Last Updated
August 18, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share